Literature DB >> 27884456

[Neurosarcoidosis: Diagnosis and therapeutic issues].

F Cohen Aubart1, D Galanaud2, J Haroche3, D Psimaras4, A Mathian5, M Hié5, D Le-Thi Huong Boutin5, F Charlotte6, E Maillart7, T Maisonobe8, Z Amoura3.   

Abstract

Neurological localizations of sarcoidosis are heterogeneous and may affect virtually every part of the central or peripheral nervous system. They are often the inaugural manifestation of sarcoidosis. The diagnosis may be difficult due to the lack of extra-neurological localization. Diagnosis may be discussed in the presence of an inflammatory neurological disease, in particular in case of suggestive radiological or biological pattern. Cerebrospinal fluid analysis shows lymphocytic pleiocytosis, often with low glucose level. The diagnosis relies on a clinical, biological and radiological presentation consistent with neurosarcoidosis, the presence of non-caseating granuloma and exclusion of differential diagnoses. Screening for other localizations of sarcoidosis, in particular cardiac disease may be obtained during neurosarcoidosis. The treatment of neurosarcoidosis relies on corticosteroids although immunosuppressive drugs are usually added because of the chronic course of this condition and to limit the side effects of steroids. Treatments and follow-up may be prolonged because of the high rate of relapses.
Copyright © 2016 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Antagonistes du TNFα; Corticosteroids; Corticostéroïdes; Granulomas; Granulome; Immunosuppresseurs; Immunosuppressive drugs; Neurosarcoidosis; Neurosarcoïdose; Sarcoidosis; Sarcoïdose; TNFα antagonists

Mesh:

Substances:

Year:  2016        PMID: 27884456     DOI: 10.1016/j.revmed.2016.10.392

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis.

Authors:  Vincent Jachiet; Raphael Lhote; Pierre Rufat; Micheline Pha; Julien Haroche; Sophie Crozier; Corinne Dupel-Potier; Dimitri Psimaras; Zahir Amoura; Fleur Cohen Aubart
Journal:  J Neurol       Date:  2018-08-14       Impact factor: 4.849

2.  Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Authors:  Fleur Cohen Aubart; Salam Abbara; Thierry Maisonobe; Vincent Cottin; Thomas Papo; Julien Haroche; Alexis Mathian; Micheline Pha; Laurent Gilardin; Baptiste Hervier; Michael Soussan; Philippe Morlat; Hilario Nunes; Olivier Benveniste; Zahir Amoura; Dominique Valeyre
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-16

Review 3.  How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.

Authors:  Dominique Valeyre; Florence Jeny; Cécile Rotenberg; Diane Bouvry; Yurdagül Uzunhan; Pascal Sève; Hilario Nunes; Jean-François Bernaudin
Journal:  Adv Ther       Date:  2021-07-22       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.